Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 31, 2013EMBO Molecular MedicineOpen Access

Sox2 promotes tamoxifen resistance in breast cancer cells

View Full Paper
Ask AI
Bookmark
Share

Authors

MPMarco PivaIkerbasqueGDGiacomo DomeniciInstituto de Biologia Experimental e TecnológicaOIOihana IriondoIkerbasque

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Piva et al. (2013) studied this question.

synapsesocial.com/papers/6a6fa696febe604dd70884e1https://doi.org/10.1002/emmm.201303411
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer1999 · 2,081 citations
  2. 2In lymph node‐negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor2003 · 49 citations
  3. 3Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism2006 · 293 citations
  4. 4The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types2007 · 160 citations
  5. 5Function Follows Form: Defining Mammary Stem Cells2010 · 15 citations